These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study. Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821 [TBL] [Abstract][Full Text] [Related]
43. Drug strategies for airflow obstruction. Petty TL Am J Nurs; 1987 Feb; 87(2):180-4. PubMed ID: 2880508 [No Abstract] [Full Text] [Related]
44. A computational study of the respiratory airflow characteristics in normal and obstructed human airways. Sul B; Wallqvist A; Morris MJ; Reifman J; Rakesh V Comput Biol Med; 2014 Sep; 52():130-43. PubMed ID: 25058489 [TBL] [Abstract][Full Text] [Related]
45. Structural basis for airflow limitation in chronic obstructive pulmonary disease. Saetta M; Turato G; Zuin R Sarcoidosis Vasc Diffuse Lung Dis; 2000 Oct; 17(3):239-45. PubMed ID: 11033839 [TBL] [Abstract][Full Text] [Related]
46. Bronchial hyperreactivity, annual rate of decline in FEV1 and chronic airflow obstruction: relationship with smoking. Pande JN Indian J Chest Dis Allied Sci; 1984; 26(4):203-4. PubMed ID: 6545260 [No Abstract] [Full Text] [Related]
47. Symptoms and signs in the assessment of chronic airflow obstruction. Bohadana AB; Mohankumar T Indian J Chest Dis Allied Sci; 1982; 24(2-3):133-42. PubMed ID: 7166350 [No Abstract] [Full Text] [Related]
48. COPD: management and rehabilitation. Make B Am Fam Physician; 1991 Apr; 43(4):1315-24. PubMed ID: 2008819 [TBL] [Abstract][Full Text] [Related]
49. Trials of steroids in patients with chronic airflow obstruction. Rudolf M Postgrad Med J; 1983; 59 Suppl 3():68-70. PubMed ID: 6359111 [TBL] [Abstract][Full Text] [Related]
50. Mechanisms of airflow obstruction: role of cells and mediators. Rennard SI; Romberger DJ; Spurzem JR Monaldi Arch Chest Dis; 1993 Oct; 48(5):407-10. PubMed ID: 8312890 [No Abstract] [Full Text] [Related]
51. Chronic airflow obstruction. Evolution of disordered function in cigarette smokers. Colebatch HJ; Greaves IA Med J Aust; 1985 May; 142(11):607-10. PubMed ID: 4000025 [TBL] [Abstract][Full Text] [Related]
52. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Snider GL Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S3-8. PubMed ID: 2675711 [TBL] [Abstract][Full Text] [Related]
53. Precise diagnosis of airflow obstruction--does it matter for treatment? SEPCR Workshop, Wiesbaden 1989. Eur Respir J; 1990 Oct; 3(9):1078-97. PubMed ID: 2289560 [No Abstract] [Full Text] [Related]
54. Assessing and ensuring drug compliance in chronic respiratory disease. SEPCR-ERS Workshop. Wiesbaden, 1990. Eur Respir J; 1992 Jan; 5(1):122-45. PubMed ID: 1349536 [No Abstract] [Full Text] [Related]
55. Precise diagnosis of airflow obstruction - does it matter for treatment? Some problems with current labels. Pride NB Eur Respir J; 1990 Oct; 3(9):1078-80. PubMed ID: 2289559 [No Abstract] [Full Text] [Related]
56. Precise diagnosis of airflow obstruction - does it matter for treatment? The assessment of reversibility: short-term. Wettengel R Eur Respir J; 1990 Oct; 3(9):1088-9. PubMed ID: 2289564 [No Abstract] [Full Text] [Related]